SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SYNTHETECH - NZYM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (297)10/19/1999 12:51:00 PM
From: Dan Gibbs  Read Replies (1) of 372
 
Tuck,

I didn't mean to sound gloomy. Earnings will be down short term because the huge Roche order is gone (some of that was probably still booked in the last quarter.) However on the plus side, the company is using this down time to expand the new plant and gear up for the next big orders. They will come and when they do, NZYM will be able to handle them even more efficiently and probably with better margins. Nobody knows when those big orders will come, but there are 10-12 projects winding their way through clinical trials that use NZYM products. Some of those are bound to take off, probably within the next 12-18 months (my guess).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News